Development of clinical prediction score for failure of antithyroid drug treatment in Graves'disease patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20260209007

Enrollment

385

Registered

2026-02-09

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical prediction score for failure of antithyroid drug treatment in Graves&#039

Interventions

Graves&#039

disease patients who cannot discontinue antithyroid drug after 2 years of more,Graves&#039

disease patients who achieve remission after antithyroid drug treatmet, confirmed by euthyroid clinical and normal thyroid hormone level

Treatment,Treatment

Failure,Remission

Eligibility

Sex/Gender

All

Age

15 Years to 95 Years

Inclusion criteria

Inclusion criteria: Graves' disease patients with 1.Age 15 years or more 2. treat and regularly follow up at Surin Hospitsl

Exclusion criteria

Exclusion criteria: Graves' disease patients with 1. thyroid storm 2.Pregnancy 3.who choose radioactive iodine ablation 4.bed ridden status or short lifespan

Design outcomes

Primary

Measure	Time frame
Failure of antithyroid drug treatment at least 6 months after antithyroid drug treatment clinical parameters, clinical prediction score	—

Secondary

Measure	Time frame
none none none	—

Countries

Thailand

Contacts

Public ContactSuwanna Pitchaiprasert

Department of medicine, Surin Hospital

noongningmd59@gmail.com0830627783

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026

Development of clinical prediction score for failure of antithyroid drug treatment in Graves&#039;disease patients